03809nam 2200589Ia 450 991078020810332120230617011757.01-280-01133-592-4-068157-49786610011339(CKB)111087027685714(EBL)284793(OCoLC)191039475(SSID)ssj0000271407(PQKBManifestationID)11192927(PQKBTitleCode)TC0000271407(PQKBWorkID)10293689(PQKB)10729267(MiAaPQ)EBC284793(Au-PeEL)EBL284793(CaPaEBR)ebr10040297(EXLCZ)9911108702768571420030508d2003 uh 0engur|n|---|||||txtccrWHO Expert Committee on Specifications for Pharmaceutical Preparations[electronic resource] thirty-seventh reportGeneva World Health Organization20031 online resource (145 p.)WHO technical report series,0512-3054 ;908Description based upon print version of record.92-4-120908-9 0-585-49271-9 1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main principles -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals.This report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. The report is complemented by a number of annexes. These include: a list of available international chemical reference substances and international infrared spectra; supplementary guidelines on good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical dosage forms; updated supplementary guideliTechnical report series (World Health Organization) ;908.DrugsStandardsCongressesDrugsSpecificationsCongressesPharmaceutical industryQuality controlCongressesDrugsStandardsDrugsSpecificationsPharmaceutical industryQuality control615.19MiAaPQMiAaPQMiAaPQBOOK9910780208103321WHO Expert Committee on Specifications for Pharmaceutical Preparations1917970UNINA01552nas 2200505- 450 991024574760332120241223110053.02519-5638(OCoLC)982736449(CKB)3710000001079835(CONSER)--2023242874(MiFhGG)01LM(DE-599)ZDB3007365-0(MiAaPQ)2044902(EXLCZ)99371000000107983520170419a20169999 |-- -engur|||||||||||txtrdacontentcrdamediacrrdacarrierTransformation in higher educationDurbanville, Cape Town, South Africa :AOSIS,2016-1 online resourceRefereed/Peer-reviewed2415-0991 Education, HigherSouth AfricaPeriodicalsEnseignement supérieurAfrique du SudPériodiquesEducation, HigherfastSouth Africafasthttps://id.oclc.org/worldcat/entity/E39PBJcWtkkqd3cMmFw9GBdYT3Periodicalperiodicals.aatPeriodicalsfastZeitschrift.gnd-contentPeriodicals.lcgftPériodiques.rvmgfEducation, HigherEnseignement supérieurEducation, Higher370BIFO-HFDE-11fidJOURNAL9910245747603321Transformation in higher education2410179UNINA